Lupus Clinical Trials in Chicago

Showing 101-119 of 119 trials

Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome

NCT00603044

The purpose of this research is to find out how a nasal spray (fluticasone furoate), sometimes given to children with obstructive sleep apnea syndrome (OSAS), works on certain cells within a child's adenoids. We hypothesize that intranasal steroids lead to an upregulation of T regulatory cells in the adenoid tissues of children with OSAS. This will result in a local reduction in inflammation and edema explaining the improvement in OSAS.

Childhood Obstructive Sleep Apnea Syndrome (OSAS)

University of Chicago24 participantsStarted Jan 2008

Chicago, Illinois, United States

WITHDRAWNPHASE32.2 miles

Study of Epratuzumab in Systemic Lupus Erythematosus

NCT00382837

Epratuzumab is an investigational antibody designed to help treat SLE. The purpose is to evaluate safety and long term efficacy in concert with standard SLE treatments

Systemic Lupus Erythematosus

UCB PharmaStarted Jan 2007

Birmingham, Alabama, United States • Tucson, Arizona, United States • Los Angeles, California, United States +51 more locations

Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome

Study of Epratuzumab in Systemic Lupus Erythematosus

Lupus Trials in Other Cities

PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

Sleep Disturbances as a Non-traditional Risk Factor in CKD-Actigraphy

Systemic Steroids Plus Antibiotics in Sleep Apnea Syndrome in Children

Sleep Disordered Breathing and Diabetes

Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder

Brain Oxygenation and Hemodynamics During Sleep in Obstructive Sleep Apnea Sufferers

To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids

Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL

Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus

Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age

Efficacy and Safety of SR46349B in Patients With Sleep Disorders in Fibromyalgia

PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus

Feasibility Study to Determine the Effects of Phrenic Nerve Stimulation in Patients With Periodic Breathing

Etanercept for the Treatment of Lupus Nephritis

Study of Epratuzumab in Systemic Lupus Erythematosus

Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year

Other Conditions in Chicago